Equities researchers at FinnCap initiated coverage on shares of Cello Group plc (LON:CLL) in a research report issued to clients and investors on Wednesday. The brokerage set a “buy” rating and a GBX 132 ($1.72) price target on the stock. FinnCap’s price target suggests a potential upside of 23.94% from the stock’s previous close.
A number of other brokerages have also issued reports on CLL. Cenkos Securities Ltd reissued a “buy” rating on shares of Cello Group plc in a research report on Wednesday, September 14th. N+1 Singer reissued a “buy” rating on shares of Cello Group plc in a research report on Wednesday, September 14th. Finally, Peel Hunt reissued a “buy” rating and issued a GBX 130 ($1.70) target price on shares of Cello Group plc in a research report on Tuesday, July 26th. Five research analysts have rated the stock with a buy rating, Cello Group plc has a consensus rating of “Buy” and a consensus price target of GBX 123.75 ($1.62).
Cello Group plc (LON:CLL) opened at 107.4999 on Wednesday. The company has a 50-day moving average price of GBX 105.32 and a 200-day moving average price of GBX 98.55. The stock’s market cap is GBX 93.32 million. Cello Group plc has a 52 week low of GBX 77.10 and a 52 week high of GBX 115.00.
The firm also recently declared a dividend, which will be paid on Friday, November 4th. Shareholders of record on Thursday, October 6th will be paid a GBX 1 ($0.01) dividend. The ex-dividend date is Thursday, October 6th. This represents a dividend yield of 0.94%.
About Cello Group plc
Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company’s pharmaceutical and healthcare clients.
Receive News & Ratings for Cello Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cello Group plc and related companies with MarketBeat.com's FREE daily email newsletter.